HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 28 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $922,000 | +172.0% | 1,387,665 | +579.6% | 0.01% | +225.0% |
| Q2 2019 | $339,000 | -72.3% | 204,189 | -58.3% | 0.00% | -75.0% |
| Q1 2019 | $1,224,000 | -1.3% | 489,475 | +0.3% | 0.02% | -11.1% |
| Q4 2018 | $1,240,000 | +26.8% | 488,000 | +62.7% | 0.02% | +100.0% |
| Q2 2018 | $978,000 | +150.1% | 300,000 | +234.4% | 0.01% | +125.0% |
| Q4 2015 | $391,000 | -55.1% | 89,722 | -21.4% | 0.00% | -60.0% |
| Q3 2015 | $870,000 | -62.4% | 114,113 | -45.0% | 0.01% | -23.1% |
| Q2 2015 | $2,312,000 | – | 207,338 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 2,426,300 | $802,000 | 0.74% |
| Cowen Prime Services LLC | 1,411,500 | $466,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 1,205,873 | $398,000 | 0.07% |
| Nantahala Capital Management | 5,113,958 | $1,690,000 | 0.05% |
| HighMark Wealth Management LLC | 80,000 | $26,000 | 0.02% |
| Kalos Management, Inc. | 72,858 | $24,000 | 0.01% |
| Qube Research & Technologies Ltd | 585,187 | $193,000 | 0.00% |
| WINTON GROUP Ltd | 190,146 | $63,000 | 0.00% |
| Ironwood Financial, llc | 1,571 | $1,000 | 0.00% |
| Virtu Financial LLC | 12,049 | $4,000 | 0.00% |